Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02304913

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Universität Duisburg-Essen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Detailed description

Taste disorders are frequent side effects in patients undergoing chemotherapy (CTX). Dysguesia has prevalence rates of 16% to 1000% during CTX with sometimes also persistent courses. Impact of dysguesia on appetite, body weight as well as health-related quality of life was shown. Until now, evidence for adequate treatment options is limited to specific diary recommendations. Acupuncture in the treatment of side effects of chemotherapy was investigated for nausea and xerostomia, but not for dysguesia. Therefore, this randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Conditions

Interventions

TypeNameDescription
OTHERHypoglossal acupuncture
OTHERSham acupuncture
BEHAVIORALDietary recommendations

Timeline

Start date
2015-01-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2014-12-02
Last updated
2026-04-14

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02304913. Inclusion in this directory is not an endorsement.